NCT06869824

The Efficacy of Minayo Iron-rich Nutritional Gummies on Female Anemia, Skin Condition and Qi-blood Deficiency Syndrome

A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy of Minayo Iron-rich Nutritional Gummies on Female Anemia, Skin Condition and Qi-blood Deficiency Syndrome

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 36 (actual)
• Sponsor: Hangzhou Agile Groups Network Technology Co., Ltd. · Industry
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The goal of this randomized, double-blind, placebo controlled study is to learn about the efficacy of Minayo Iron-rich Nutritional Gummies on females who are aged 18-45 and suffer nutritional Anemia, skin condition and Qi-blood deficiency syndrome. The main question it aims to answer is: \- whether the Anemia (measured by serum ferritin level and hemoglobin concentration Level in blood) is improved after the intervention 36 qualified participants will be enrolled and assigned to two equal-size groups with study product (Minayo Iron-rich Nutritional Gummies) and placebo product (common gummies) in one study center in Shanghai. The study will last 4 weeks and three site visits will be made, during which all clinical data will be captured and entered to EDC system for statistical analysis and reporting. Researchers will find out whether the study product (Minayo Iron-rich Nutritional Gummies) is effective to improve Anemia, skin conditions, and Qi-blood deficiency symptoms by comparing the two groups.

Conditions

• Anemia
• Skin Condition
• Qi-blood Deficiency Syndrome

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Minayo Iron-rich Nutritional Gummies	Participants need to eat one piece of the assigned product after meal three times a day, for 4 consecutive weeks.
DIETARY_SUPPLEMENT	Common Gummies	Participants need to eat one piece of the assigned product after meal three times a day, for 4 consecutive weeks.

Timeline

• Start date: 2025-03-17
• Primary completion: 2025-04-13
• Completion: 2025-04-13
• First posted: 2025-03-11
• Last updated: 2025-07-03

Locations

1 site across 1 country: China